{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:44:16Z","timestamp":1794487456698,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03578-0","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T19:18:31Z","timestamp":1742584711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Younger severe asthma patients with interleukin 4 (CC variant) and dupilumab treatment are more likely to achieve clinical remission"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2950-5363","authenticated-orcid":false,"given":"Mona","family":"Al-Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-5085","authenticated-orcid":false,"given":"Asmaa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"Talat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"issue":"5","key":"3578_CR1","first-page":"286","volume":"103","author":"K Narasimhan","year":"2021","unstructured":"Narasimhan K. Difficult to treat and severe asthma: management strategies. Am Fam Physician. 2021;103(5):286\u201390. PMID: 33630543.","journal-title":"Am Fam Physician"},{"issue":"10","key":"3578_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/CM9.0000000000001990","volume":"135","author":"KF Chung","year":"2022","unstructured":"Chung KF, Dixey P, Abubakar-Waziri H, Bhavsar P, Patel PH, Guo S, Ji Y. Characteristics, phenotypes, mechanisms and management of severe asthma. Chin Med J (Engl). 2022;135(10):1141\u201355. https:\/\/doi.org\/10.1097\/CM9.0000000000001990. PMID: 35633594; PMCID: PMC9337252.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"3578_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.anai.2021.10.002","volume":"128","author":"T Grant","year":"2022","unstructured":"Grant T, Croce E, Matsui EC. Asthma and the social determinants of health. Ann Allergy Asthma Immunol. 2022;128(1):5\u201311. https:\/\/doi.org\/10.1016\/j.anai.2021.10.002. Epub 2021 Oct 19. PMID: 34673220; PMCID: PMC8671352.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"3578_CR4","doi-asserted-by":"crossref","first-page":"00576","DOI":"10.1183\/23120541.00576-2021","volume":"8","author":"J Maspero","year":"2022","unstructured":"Maspero J, Adir Y, Al-Ahmad M, Celis-Preciado CA, Colodenco FD, Giavina-Bianchi P, Lababidi H, Ledanois O, Mahoub B, Perng DW, Vazquez JC, Yorgancioglu A. Type 2 inflammation in asthma and other airway diseases. ERJ Open Res. 2022;8(3):00576\u20132021. PMID: 35923421; PMCID: PMC9339769.","journal-title":"ERJ Open Res"},{"issue":"1","key":"3578_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/17476348.2017.1268919","volume":"11","author":"HS Chang","year":"2017","unstructured":"Chang HS, Lee TH, Jun JA, Baek AR, Park JS, Koo SM, Kim YK, Lee HS, Park CS. Neutrophilic inflammation in asthma: mechanisms and therapeutic considerations. Expert Rev Respir Med. 2017;11(1):29\u201340.","journal-title":"Expert Rev Respir Med"},{"issue":"168","key":"3578_CR6","doi-asserted-by":"publisher","first-page":"220201","DOI":"10.1183\/16000617.0201-2022","volume":"32","author":"FLM Ricciardolo","year":"2023","unstructured":"Ricciardolo FLM, Guida G, Bertolini F, Di Stefano A, Carriero V. Phenotype overlap in the natural history of asthma. Eur Respir Rev. 2023;32(168):220201. https:\/\/doi.org\/10.1183\/16000617.0201-2022. PMID: 37197769; PMCID: PMC10189644.","journal-title":"Eur Respir Rev"},{"issue":"4","key":"3578_CR7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jaci.2018.06.008","volume":"143","author":"O Tliba","year":"2019","unstructured":"Tliba O, Panettieri RA Jr. Paucigranulocytic asthma: uncoupling of airway obstruction from inflammation. J Allergy Clin Immunol. 2019;143(4):1287\u201394. https:\/\/doi.org\/10.1016\/j.jaci.2018.06.008. Epub 2018 Jun 19. PMID: 29928921; PMCID: PMC6301131.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3578_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00441-016-2566-8","volume":"367","author":"H Fehrenbach","year":"2017","unstructured":"Fehrenbach H, Wagner C, Wegmann M. Airway remodeling in asthma: what really matters. Cell Tissue Res. 2017;367(3):551\u201369. https:\/\/doi.org\/10.1007\/s00441-016-2566-8. Epub 2017 Feb 11. PMID: 28190087; PMCID: PMC5320023.","journal-title":"Cell Tissue Res"},{"key":"3578_CR9","doi-asserted-by":"crossref","unstructured":"Wang L, McParland BE, Par\u00e9 PD. The functional consequences of structural changes in the airways: implications for airway hyperresponsiveness in asthma. Chest. 2003;123(3 Suppl):356S-62S. PMID: 12628973.","DOI":"10.1016\/S0012-3692(15)35205-3"},{"issue":"12","key":"3578_CR10","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1111\/all.14607","volume":"75","author":"L Cevhertas","year":"2020","unstructured":"Cevhertas L, Ogulur I, Maurer DJ, Burla D, Ding M, Jansen K, Koch J, Liu C, Ma S, Mitamura Y, Peng Y, Radzikowska U, Rinaldi AO, Satitsuksanoa P, Globinska A, van de Veen W, Sokolowska M, Baerenfaller K, Gao YD, Agache I, Akdis M, Akdis CA. Advances and recent developments in asthma in 2020. Allergy. 2020;75(12):3124\u201346. https:\/\/doi.org\/10.1111\/all.14607. Epub 2020 Oct 16. PMID: 32997808.","journal-title":"Allergy"},{"issue":"3","key":"3578_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.chest.2019.10.009","volume":"157","author":"N Schoettler","year":"2020","unstructured":"Schoettler N, Strek ME. Recent advances in severe asthma: from phenotypes to personalized medicine. Chest. 2020;157(3):516\u201328. Epub 2019 Oct 31. PMID: 31678077; PMCID: PMC7609962. https:\/\/doi.org\/10.1016\/j.chest.2019.10.009","journal-title":"Chest"},{"issue":"4","key":"3578_CR12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaip.2024.01.023","volume":"12","author":"A Bourdin","year":"2024","unstructured":"Bourdin A, Brusselle G, Couillard S, Fajt ML, Heaney LG, Israel E, McDowell PJ, Menzies-Gow A, Martin N, Mitchell PD, Petousi N, Quirce S, Schleich F, Pavord ID. Phenotyping of severe asthma in the era of Broad-Acting Anti-Asthma biologics. J Allergy Clin Immunol Pract. 2024;12(4):809\u201323. Epub 2024 Jan 25. PMID: 38280454.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3578_CR13","doi-asserted-by":"publisher","first-page":"637948","DOI":"10.3389\/fimmu.2021.637948","volume":"12","author":"B Le\u00f3n","year":"2021","unstructured":"Le\u00f3n B, Ballesteros-Tato A. Modulating Th2 cell immunity for the treatment of asthma. Front Immunol. 2021;12:637948. https:\/\/doi.org\/10.3389\/fimmu.2021.637948. PMID: 33643321; PMCID: PMC7902894.","journal-title":"Front Immunol"},{"key":"3578_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fmed.2018.00049","volume":"5","author":"F Roufosse","year":"2018","unstructured":"Roufosse F. Targeting the Interleukin-5 pathway for treatment of eosinophilic conditions other than asthma. Front Med (Lausanne). 2018;5:49. https:\/\/doi.org\/10.3389\/fmed.2018.00049. PMID: 29682504; PMCID: PMC5897501.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"3578_CR15","doi-asserted-by":"publisher","first-page":"CD012929","DOI":"10.1002\/14651858.CD012929.pub2","volume":"10","author":"A Gallagher","year":"2021","unstructured":"Gallagher A, Edwards M, Nair P, Drew S, Vyas A, Sharma R, Marsden PA, Wang R, Evans DJ. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma. Cochrane Database Syst Rev. 2021;10(10):CD012929. https:\/\/doi.org\/10.1002\/14651858.CD012929.pub2. PMID: 34664263; PMCID: PMC8524317.","journal-title":"Cochrane Database Syst Rev"},{"key":"3578_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molimm.2022.03.119","volume":"146","author":"RM Alsaffar","year":"2022","unstructured":"Alsaffar RM, Alkholifi FK. Exploring the efficacy and contribution of dupilumab in asthma management. Mol Immunol. 2022;146:9\u201317. https:\/\/doi.org\/10.1016\/j.molimm.2022.03.119. Epub 2022 Apr 6. PMID: 35397375.","journal-title":"Mol Immunol"},{"issue":"5","key":"3578_CR17","doi-asserted-by":"publisher","first-page":"2102583","DOI":"10.1183\/13993003.02583-2021","volume":"60","author":"D Thomas","year":"2022","unstructured":"Thomas D, McDonald VM, Pavord ID, Gibson PG. Asthma remission: what is it and how can it be achieved? Eur Respir J. 2022;60(5):2102583. https:\/\/doi.org\/10.1183\/13993003.02583-2021. PMID: 35361633; PMCID: PMC9630609.","journal-title":"Eur Respir J"},{"key":"3578_CR18","doi-asserted-by":"crossref","unstructured":"Pelaia C, Zannoni E, Paoletti G, Marzio V, Heffler E, Carr\u00f3n-Herrero A. Clinical remission in severe asthma: lights and shadows on an ambitious goal. Current opinion in allergy and clinical immunology. 2024 May 1:10\u201397.","DOI":"10.1097\/ACI.0000000000000991"},{"issue":"3","key":"3578_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41584-020-00543-5","volume":"17","author":"G Schett","year":"2021","unstructured":"Schett G, Tanaka Y, Isaacs JD. Why remission is not enough: underlying disease mechanisms in RA that prevent cure. Nat Rev Rheumatol. 2021;17(3):135\u201344. https:\/\/doi.org\/10.1038\/s41584-020-00543-5. Epub 2020 Dec 10. PMID: 33303993.","journal-title":"Nat Rev Rheumatol"},{"key":"3578_CR20","doi-asserted-by":"publisher","unstructured":"Caron B, Jairath V, Laurent V, Stoker J, Laghi A, D\u2019Haens GR et al. Defining magnetic resonance imaging treatment response and remission in Crohn\u2019s disease: a systematic review. J Crohns Colitis. 2023 Jul 31:jjad125. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad125. Epub ahead of print. PMID: 37523157.","DOI":"10.1093\/ecco-jcc\/jjad125"},{"issue":"3","key":"3578_CR21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","volume":"145","author":"A Menzies-Gow","year":"2020","unstructured":"Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, et al. An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol. 2020;145(3):757\u201365. Epub 2019 Dec 19. PMID: 31866436.","journal-title":"J Allergy Clin Immunol"},{"key":"3578_CR22","doi-asserted-by":"publisher","unstructured":"Lugogo NL, Mohan A, Akuthota P, Couillard S, Rhoads S, Wechsler ME. Are We Ready for Asthma Remission as a Clinical Outcome? Chest. 2023;164(4):831\u2013834. https:\/\/doi.org\/10.1016\/j.chest.2023.04.028. PMID: 37805244.","DOI":"10.1016\/j.chest.2023.04.028"},{"key":"3578_CR23","doi-asserted-by":"publisher","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP, Brightling C, Chanez P, Dahlen SE, Djukanovic R, Frey U, Gaga M, Gibson P, Hamid Q, Jajour NN, Mauad T, Sorkness RL, Teague WG. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343\u2013\u200973. https:\/\/doi.org\/10.1183\/09031936.00202013. Epub 2013 Dec 12. Erratum in: Eur Respir J. 2014;43(4):1216. Dosage error in article text. Erratum in: Eur Respir J. 2018;52(1): Erratum in: Eur Respir J. 2022;59(6): PMID: 24337046.","DOI":"10.1183\/09031936.00202013"},{"key":"3578_CR24","doi-asserted-by":"crossref","unstructured":"Louis R, Satia I, Ojanguren I, Schleich F, Bonini M, Tonia T, Rigau D, Ten Brinke A, Buhl R, Loukides S, Kocks JWH, Boulet LP, Bourdin A, Coleman C, Needham K, Thomas M, Idzko M, Papi A, Porsbjerg C, Schuermans D, Soriano JB, Usmani OS. European respiratory society guidelines for the diagnosis of asthma in adults. Eur Respir J 2022 Feb 15:2101585. doi: 10.1183\/13993003.01585-2021. Epub ahead of print. PMID: 35169025.","DOI":"10.1183\/13993003.01585-2021"},{"issue":"2","key":"3578_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.24191\/jchs.v6i2.14942","volume":"6","author":"MA Ibrahim","year":"2021","unstructured":"Ibrahim MA, Ismail AI, Rani MF. A brief review of severe asthma. J Clin Health Sci. 2021;6(2):4\u201312.","journal-title":"J Clin Health Sci"},{"issue":"1","key":"3578_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12890-018-0621-9","volume":"18","author":"H Tarraf","year":"2018","unstructured":"Tarraf H, Aydin O, Mungan D, Albader M, Mahboub B, Doble A, Lahlou A, Tariq L, Aziz F, El Hasnaoui A. Prevalence of asthma among the adult general population of five middle Eastern countries: results of the SNAPSHOT program. BMC Pulm Med. 2018;18(1):68. https:\/\/doi.org\/10.1186\/s12890-018-0621-9. PMID: 29751756; PMCID: PMC5948696.","journal-title":"BMC Pulm Med"},{"issue":"12","key":"3578_CR27","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/14712598.2020.1809651","volume":"20","author":"A Bakakos","year":"2020","unstructured":"Bakakos A, Loukides S, Usmani OS, Bakakos P. Biologics in severe asthma: the overlap endotype - opportunities and challenges. Expert Opin Biol Ther. 2020;20(12):1427\u201334. Epub 2020 Aug 25. PMID: 32779950.","journal-title":"Expert Opin Biol Ther"},{"key":"3578_CR28","doi-asserted-by":"publisher","first-page":"106586","DOI":"10.1016\/j.rmed.2021.106586","volume":"187","author":"M Al-Ahmad","year":"2021","unstructured":"Al-Ahmad M, Nurkic J, Othman Y, Jusufovic E, Maher A. Severe asthma in Kuwait population: Phenotype-based approach. Respir Med. 2021;187:106586. https:\/\/doi.org\/10.1016\/j.rmed.2021.106586. Epub 2021 Aug 27. PMID: 34474336.","journal-title":"Respir Med"},{"issue":"8","key":"3578_CR29","first-page":"1015","volume":"13","author":"M Khadadah","year":"2009","unstructured":"Khadadah M, Mahboub B, Al-Busaidi NH, Sliman N, Soriano JB, Bahous J. Asthma insights and reality in the Gulf and the near East. Int J Tuberc Lung Dis. 2009;13(8):1015\u201322. PMID: 19723383.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3578_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2147\/JAA.S429981","volume":"16","author":"M Al-Ahmad","year":"2023","unstructured":"Al-Ahmad M, Ali A, Haider MZ. Interleukin-4 (C590T) gene polymorphism in association with asthma severity. J Asthma Allergy. 2023;16:1269\u201378. https:\/\/doi.org\/10.2147\/JAA.S429981. PMID: 38022750; PMCID: PMC10676224.","journal-title":"J Asthma Allergy"},{"key":"3578_CR31","doi-asserted-by":"crossref","unstructured":"Al-Ahmad M, Ali A, Haider MZ. Interleukin-4 (C590T), Interleukin-6 (174G\/C), Interleukin-13 (rs20541) and Tumor Necrotic Factor-\u03b1 (G308A) Gene Polymorphisms and Clinical Markers as Predictors of Asthma Severity: Insights from a Comparative Study. European Respiratory Society (ERS) conference (September 2024). Page (188). https:\/\/www.ersnet.org\/wp-content\/uploads\/2024\/07\/Congress-Programme-2024-0807.pdf.","DOI":"10.1183\/13993003.congress-2024.PA3078"},{"issue":"2","key":"3578_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/1817-1737.39635","volume":"3","author":"H Lababidi","year":"2008","unstructured":"Lababidi H, Hijaoui A, Zarzour M. Validation of the Arabic version of the asthma control test. Ann Thorac Med. 2008;3(2):44\u20137. https:\/\/doi.org\/10.4103\/1817-1737.39635. PMID: 19561904; PMCID: PMC2700459.","journal-title":"Ann Thorac Med"},{"key":"3578_CR33","doi-asserted-by":"publisher","unstructured":"Juniper EF, O\u2019Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902-7. https:\/\/doi.org\/10.1034\/j.1399-3003.1999.14d29.x. PMID: 10573240.","DOI":"10.1034\/j.1399-3003.1999.14d29.x"},{"key":"3578_CR34","unstructured":"eProvide. Asthma Control Questionnaire (ACQ) Package - Paper Use [Internet]. Lyon (France): Mapi Research Trust; [cited 2025 Jan 24]. Available from: https:\/\/eprovide.mapi-trust.org\/instruments\/asthma-control-questionnaire-package-paper-use"},{"issue":"3","key":"3578_CR35","doi-asserted-by":"publisher","first-page":"e14669","DOI":"10.1111\/dme.14669","volume":"39","author":"MC Riddle","year":"2022","unstructured":"Riddle MC, Cefalu WT, Evans PH, Gerstein HC, Nauck MA, Oh WK, Rothberg AE, le Roux CW, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabet Med. 2022;39(3):e14669. https:\/\/doi.org\/10.1111\/dme.14669. Epub 2021 Aug 30. PMID: 34460965.","journal-title":"Diabet Med"},{"key":"3578_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pharmthera.2019.05.002","volume":"201","author":"OA Carpaij","year":"2019","unstructured":"Carpaij OA, Burgess JK, Kerstjens HAM, Nawijn MC, van den Berge M. A review on the pathophysiology of asthma remission. Pharmacol Ther. 2019;201:8\u201324. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.05.002. Epub 2019 May 8. PMID: 31075356.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"3578_CR37","doi-asserted-by":"publisher","first-page":"2300819","DOI":"10.1183\/13993003.00819-2023","volume":"62","author":"PJ McDowell","year":"2023","unstructured":"McDowell PJ, McDowell R, Busby J, Eastwood MC, Patel PH, Jackson DJ, Mansur A, Patel M, Burhan H, Doe S, Chaudhuri R, Gore R, Dodd JW, Subramanian D, Brown T, Heaney LG, UK Severe Asthma Registry. Clinical remission in severe asthma with biologic therapy: an analysis from the UK severe asthma registry. Eur Respir J. 2023;62(6):2300819. https:\/\/doi.org\/10.1183\/13993003.00819-2023. PMID: 37857423; PMCID: PMC10719453.","journal-title":"Eur Respir J"},{"issue":"1","key":"3578_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12865-020-00384-7","volume":"21","author":"A Kousha","year":"2020","unstructured":"Kousha A, Mahdavi Gorabi A, Forouzesh M, Hosseini M, Alexander M, Imani D, Razi B, Mousavi MJ, Aslani S, Mikaeili H. Interleukin 4 gene polymorphism (-589\u00a0C\/T) and the risk of asthma: a meta-analysis and met-regression based on 55 studies. BMC Immunol. 2020;21(1):55. https:\/\/doi.org\/10.1186\/s12865-020-00384-7. PMID: 33087044; PMCID: PMC7579954.","journal-title":"BMC Immunol"},{"key":"3578_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.12703\/r\/10-71","volume":"10","author":"AD Keegan","year":"2021","unstructured":"Keegan AD, Leonard WJ, Zhu J. Recent advances in Understanding the role of IL-4 signaling. Fac Rev. 2021;10:71. https:\/\/doi.org\/10.12703\/r\/10-71. PMID: 34557875; PMCID: PMC8442009.","journal-title":"Fac Rev"},{"issue":"1","key":"3578_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cea.13491","volume":"50","author":"H Harb","year":"2020","unstructured":"Harb H, Chatila TA. Mechanisms of dupilumab. Clin Exp Allergy. 2020;50(1):5\u201314. https:\/\/doi.org\/10.1111\/cea.13491. Epub 2019 Sep 30. PMID: 31505066; PMCID: PMC6930967.","journal-title":"Clin Exp Allergy"},{"key":"3578_CR41","doi-asserted-by":"publisher","unstructured":"Shalaby SM, Radwan MI, Abdelazim S, Nafee AM. Interleukin-4 polymorphisms and response to combination therapy in Egyptian chronic hepatitis C patients. Cell Immunol. 2012 Mar-Apr;276(1\u20132):110\u20133. https:\/\/doi.org\/10.1016\/j.cellimm.2012.04.009. Epub 2012 Apr 21. PMID: 22594992.","DOI":"10.1016\/j.cellimm.2012.04.009"},{"issue":"2","key":"3578_CR42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.61186\/rbmb.11.2.238","volume":"11","author":"AK Aldhalmi","year":"2022","unstructured":"Aldhalmi AK, Al-Athari AJH, Makki Al-Hindy HA. Association of tumor necrosis Factor-\u03b1 and myeloperoxidase enzyme with severe asthma: A comparative study. Rep Biochem Mol Biol. 2022;11(2):238\u201345. PMID: 36164624; PMCID: PMC9455177.","journal-title":"Rep Biochem Mol Biol"},{"issue":"10","key":"3578_CR43","first-page":"13739","volume":"8","author":"YH Yang","year":"2015","unstructured":"Yang YH, Liu YQ, Zhang L, Li H, Li XB, Ouyang Q, Zhu GY. Genetic polymorphisms of the TNF-\u03b1-308G\/A are associated with metabolic syndrome in asthmatic patients from Hebei Province, China. Int J Clin Exp Pathol. 2015;8(10):13739\u201346. PMID: 26722602; PMCID: PMC4680547.","journal-title":"Int J Clin Exp Pathol"},{"key":"3578_CR44","doi-asserted-by":"publisher","unstructured":"A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet. 1997;15(4):389\u2013\u200992. doi: 10.1038\/ng0497-389. Erratum in: Nat Genet. 2020;52(12):1433. https:\/\/doi.org\/10.1038\/s41588-020-0650-1. PMID: 9090385.","DOI":"10.1038\/s41588-020-0650-1"},{"issue":"1","key":"3578_CR45","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1186\/s40064-016-3197-y","volume":"5","author":"RR El-Tahan","year":"2016","unstructured":"El-Tahan RR, Ghoneim AM, El-Mashad N. TNF-\u03b1 gene polymorphisms and expression. Springerplus. 2016;5(1):1508. https:\/\/doi.org\/10.1186\/s40064-016-3197-y. PMID: 27652081; PMCID: PMC5014780.","journal-title":"Springerplus"},{"key":"3578_CR46","doi-asserted-by":"publisher","unstructured":"Oettgen HC. Mast cells and tumour necrosis factor alpha (TNF-\u03b1): partners in crime in asthma pathogenesis. Clin Immunol. 2011;140(1):1\u20132. https:\/\/doi.org\/10.1016\/j.clim.2011.04.001. Epub 2011 Apr 7. PMID: 21514238.","DOI":"10.1016\/j.clim.2011.04.001"},{"issue":"11","key":"3578_CR47","doi-asserted-by":"publisher","first-page":"L1168","DOI":"10.1152\/ajplung.00393.2014","volume":"308","author":"AS Williams","year":"2015","unstructured":"Williams AS, Mathews JA, Kasahara DI, Wurmbrand AP, Chen L, Shore SA. Innate and ozone-induced airway hyperresponsiveness in obese mice: role of TNF-\u03b1. Am J Physiol Lung Cell Mol Physiol. 2015;308(11):L1168\u201377. https:\/\/doi.org\/10.1152\/ajplung.00393.2014. Epub 2015 Apr 3. PMID: 25840999; PMCID: PMC4451401.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"3578_CR48","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/biomedicines9091096","volume":"9","author":"FLM Ricciardolo","year":"2021","unstructured":"Ricciardolo FLM, Bertolini F, Carriero V. The role of dupilumab in severe asthma. Biomedicines. 2021;9(9):1096. https:\/\/doi.org\/10.3390\/biomedicines9091096. PMID: 34572281; PMCID: PMC8468984.","journal-title":"Biomedicines"},{"issue":"1","key":"3578_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1164\/rccm.201611-2232PP","volume":"197","author":"TF Carr","year":"2018","unstructured":"Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med. 2018;197(1):22\u201337. https:\/\/doi.org\/10.1164\/rccm.201611-2232PP. PMID: 28910134; PMCID: PMC5765385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3578_CR50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","volume":"178","author":"P Haldar","year":"2008","unstructured":"Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218\u201324. https:\/\/doi.org\/10.1164\/rccm.200711-1754OC. Epub 2008 May 14. PMID: 18480428; PMCID: PMC3992366.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3578_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","volume":"181","author":"WC Moore","year":"2010","unstructured":"Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D\u2019Agostino R Jr, Castro M, Curran-Everett D, Fitzpatrick AM, Gaston B, Jarjour NN, Sorkness R, Calhoun WJ, Chung KF, Comhair SA, Dweik RA, Israel E, Peters SP, Busse WW, Erzurum SC, Bleecker ER. National heart, lung, and blood institute\u2019s severe asthma research program. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010;181(4):315\u201323. https:\/\/doi.org\/10.1164\/rccm.200906-0896OC. Epub 2009 Nov 5. PMID: 19892860; PMCID: PMC2822971.","journal-title":"Am J Respir Crit Care Med"},{"key":"3578_CR52","doi-asserted-by":"publisher","unstructured":"Kaur R, Chupp G. Phenotypes and endotypes of adult asthma: Moving toward precision medicine. J Allergy Clin Immunol. 2019;144(1):1\u201312. https:\/\/doi.org\/10.1016\/j.jaci.2019.05.031. PMID: 31277742.","DOI":"10.1016\/j.jaci.2019.05.031"},{"issue":"9","key":"3578_CR53","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/jcm8091375","volume":"8","author":"A Bakakos","year":"2019","unstructured":"Bakakos A, Loukides S, Bakakos P. Severe eosinophilic asthma. J Clin Med. 2019;8(9):1375. https:\/\/doi.org\/10.3390\/jcm8091375. PMID: 31480806; PMCID: PMC6780074.","journal-title":"J Clin Med"},{"key":"3578_CR54","doi-asserted-by":"crossref","unstructured":"Pavord ID, Israel E, Szefler SJ, Brusselle G, Rabe KF, Chen Z, Altincatal A, Radwan A, Pandit-Abid N, Amin N, Jacob-Nara JA. Dupilumab induces clinical remission in patients with uncontrolled, moderate-to-severe, type 2 inflammatory asthma. InC101. IMPACT OF BIOLOGICS ON ASTHMA OUTCOMES 2023 May (pp. A5995-A5995). American Thoracic Society.","DOI":"10.1164\/ajrccm-conference.2023.207.1_MeetingAbstracts.A5995"},{"issue":"6","key":"3578_CR55","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/jpm13061020","volume":"13","author":"B Sposato","year":"2023","unstructured":"Sposato B, Bianchi F, Ricci A, Scalese M. Clinical asthma remission obtained with biologics in real life: patients\u2019 prevalence and characteristics. J Pers Med. 2023;13(6):1020. https:\/\/doi.org\/10.3390\/jpm13061020. PMID: 37374008; PMCID: PMC10305708.","journal-title":"J Pers Med"},{"key":"3578_CR56","doi-asserted-by":"publisher","first-page":"107348","DOI":"10.1016\/j.rmed.2023.107348","volume":"217","author":"A Portacci","year":"2023","unstructured":"Portacci A, Iorillo I, Quaranta VN, Maselli L, Lulaj E, Buonamico E, Dragonieri S, Carpagnano GE. Severe asthma clinical remission after biologic treatment with anti-IL4\/IL13: A real-life experience. Respir Med. 2023;217:107348. https:\/\/doi.org\/10.1016\/j.rmed.2023.107348. Epub 2023 Jul 6. PMID: 37422023.","journal-title":"Respir Med"},{"issue":"6","key":"3578_CR57","doi-asserted-by":"publisher","first-page":"563","DOI":"10.5114\/ada.2018.77607","volume":"35","author":"M Marko","year":"2018","unstructured":"Marko M, Pawliczak R. Obesity and asthma: risk, control and treatment. Postepy Dermatol Alergol. 2018;35(6):563\u201371. https:\/\/doi.org\/10.5114\/ada.2018.77607. Epub 2018 Nov 8. PMID: 30618522; PMCID: PMC6320490.","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"3578_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s41030-019-00109-1","volume":"6","author":"P Rogliani","year":"2020","unstructured":"Rogliani P, Calzetta L, Matera MG, Laitano R, Ritondo BL, Hanania NA, Cazzola M. Severe asthma and biological therapy: when, which, and for whom. Pulm Ther. 2020;6(1):47\u201366. https:\/\/doi.org\/10.1007\/s41030-019-00109-1. Epub 2019 Dec 26. PMID: 32048241; PMCID: PMC7229123.","journal-title":"Pulm Ther"},{"issue":"11","key":"3578_CR59","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1016\/j.jaip.2022.06.036","volume":"10","author":"KF Rabe","year":"2022","unstructured":"Rabe KF, FitzGerald JM, Bateman ED, Castro M, Pavord ID, Maspero JF, Busse WW, Izuhara K, Daizadeh N, Ortiz B, Pandit-Abid N, Rowe PJ, Deniz Y. Dupilumab is effective in patients with Moderate-to-Severe uncontrolled GINA-Defined type 2 asthma irrespective of an allergic asthma phenotype. J Allergy Clin Immunol Pract. 2022;10(11):2916\u2013e29244. https:\/\/doi.org\/10.1016\/j.jaip.2022.06.036. Epub 2022 Aug 23. PMID: 36028446.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03578-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T19:18:51Z","timestamp":1742584731000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03578-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03578-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants had provided written informed consent, indicating their complete understanding of the nature and objectives of the research. Participation was voluntary, and they willingly agreed to participate after being fully informed. The study approved from Kuwait Ministry of Health ethical committee office with approval number: 2256\/2023, which was aligned with local guideline as well the Helsinki Declaration protocol. This protocol ensured that the research was conducted ethically and adhered to globally recognized standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}